(E)-3-Phenyl-1-(4-(pyrimidin-2-yl)piperazin-1-yl)prop-2-en-1-one

Catalog No. :
ACLTAO401
CAS No. :
1351406-38-6
Molecular Formula :
C17H18N4O
Molecular Weight :
294.36

IUPAC Name:(E)-3-phenyl-1-(4-(pyrimidin-2-yl)piperazin-1-yl)prop-2-en-1-one

(E)-3-Phenyl-1-(4-(pyrimidin-2-yl)piperazin-1-yl)prop-2-en-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg90%$84.00Login to see priceInquiryInquiry
250mg90%$134.00Login to see priceInquiryInquiry
1g90%$332.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-3-Phenyl-1-(4-(pyrimidin-2-yl)piperazin-1-yl)prop-2-en-1-one
IUPAC Name(E)-3-phenyl-1-(4-(pyrimidin-2-yl)piperazin-1-yl)prop-2-en-1-one
Molecular FormulaC17H18N4O
Molecular Weight294.36
SMILESO=C(N1CCN(C2=NC=CC=N2)CC1)/C=C/C3=CC=CC=C3
InChI KeyXCGMDDSRZZXNOE-BQYQJAHWSA-N
Synonym(E)-3-phenyl-1-(4-pyrimidin-2-ylpiperazin-1-yl)prop-2-en-1-one;WAY-221060-A;WAY-221060
CAS No.1351406-38-6
PubChem CID6242130

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLTAO401 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRKMW197 route compound structure diagram
    ACRKMW19778069-54-2 In Stock
  4. Then
  5. ACLTAO401 route product structure diagram
    ACLTAO4011351406-38-6
Inquiry

2. ACLTAO401 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRKMW197 route compound structure diagram
    ACRKMW19778069-54-2 In Stock
  4. Then
  5. ACLTAO401 route product structure diagram
    ACLTAO4011351406-38-6
Inquiry

Comments (0)